603823.SH
百合花
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 69.98
−9.99%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.2B | 2.2B | 2.4B | 2.3B | 2.5B |
| Cost of Revenue | 1.7B | 1.7B | 1.9B | 1.9B | 2.0B |
| Gross Profit | 446.5M | 450.5M | 488.2M | 410.2M | 487.3M |
| Operating Expenses | |||||
| R&D Expense | 85.5M | 89.6M | 90.6M | 84.5M | 94.8M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 102.4M | 103.0M | 107.0M | 106.2M | 111.9M |
| Selling & Marketing Expense | 25.4M | 25.7M | 28.2M | 26.3M | 24.0M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 243.0M | 241.7M | 248.2M | 245.9M | 245.1M |
| Cost and Expenses | 2.0B | 1.9B | 2.2B | 2.1B | 2.2B |
| Operating Income (EBIT) | 205.3M | 209.2M | 228.7M | 147.7M | 241.0M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 213.4M | 217.6M | 238.0M | 159.9M | 253.4M |
| Income Tax Expense | 24.1M | 25.1M | 34.5M | 23.0M | 34.1M |
| Bottom Line | |||||
| Net Income | 164.1M | 166.9M | 176.1M | 120.2M | 214.5M |
| Earnings from Cont. Ops | 189.3M | 192.5M | 203.5M | 136.9M | 219.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 164.1M | 166.9M | 176.1M | 120.2M | 214.5M |
| Per Share | |||||
| Basic EPS | CN¥0.39 | CN¥0.40 | CN¥0.43 | CN¥0.29 | CN¥0.67 |
| Diluted EPS | CN¥0.39 | CN¥0.40 | CN¥0.43 | CN¥0.29 | CN¥0.67 |
| Revenue Per Share | CN¥5.02 | CN¥5.15 | CN¥5.87 | CN¥5.51 | CN¥7.71 |
| Shares | |||||
| Basic Shares Outstanding | 429.4M | 417.3M | 409.4M | 414.5M | 320.1M |
| Diluted Shares Outstanding | 429.4M | 417.3M | 409.4M | 414.5M | 320.1M |
| Profitability Metrics | |||||
| EBITDA | — | 358.0M | 385.7M | 301.2M | 389.9M |
| D&A | — | 148.8M | 157.0M | 153.5M | 148.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026